BioNTech and Pfizer begin study to evaluate single dose vaccine against flu and COVID-19

BioNTech and Pfizer announced today the initiation of a Phase 1 study evaluating a single dose mRNA-based combination vaccine candidate against influenza and COVID-19.

More Stories

00:22

Cold Spring Village Hall closed due to COVID-19 surge and staff shortages

Hometown Heroes in the Hudson Valley

01:28

Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines

01:52

Judge: 3 men convicted in COVID-19 relief aid fraud

01:47

Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off

00:28

Rockland small businesses get COVID-19 reimbursement grant